7Baggers
 Director’s Major Stock Sale Shakes Up Alzamend Neuro!  TipRanks Wed, 01 Oct 2025 02:06:01 GMT
 Published on: 2025-09-29 04:03:23  newser.com Mon, 29 Sep 2025 09:03:23 GMT
 Alzamend Neuro Boosts Liquidity with Stock Issuance  TipRanks Fri, 26 Sep 2025 09:17:15 GMT
 Alzamend Neuro director Ault sells $226,923 in shares  Investing.com Fri, 26 Sep 2025 01:09:02 GMT
 alzamend neuro boosts liquidity with stock issuance  TipRanks Thu, 25 Sep 2025 23:15:00 GMT
 ALZN: Ascendiant Capital Lowers Price Target While Maintaining B  GuruFocus Thu, 25 Sep 2025 12:38:56 GMT
 published on: 2025-09-22 10:23:28  newser.com Mon, 22 Sep 2025 15:23:28 GMT
 Ault Milton C III sells Alzamend Neuro (ALZN) stock for $56,696  Investing.com Australia Sat, 20 Sep 2025 03:40:25 GMT
 Ault Milton C III sells Alzamend Neuro (ALZN) stock for $56,696  Investing.com Fri, 19 Sep 2025 07:00:00 GMT
 published on: 2025-09-15 11:08:17  newser.com Mon, 15 Sep 2025 16:08:17 GMT
 published on: 2025-09-14 06:29:21  newser.com Sun, 14 Sep 2025 11:29:21 GMT
 alzamend neuro, inc. sec 10-q report  TradingView Wed, 10 Sep 2025 07:00:00 GMT
 published on: 2025-09-10 00:51:48  Newser Wed, 10 Sep 2025 05:51:48 GMT
 published on: 2025-09-09 23:18:26  Newser Wed, 10 Sep 2025 04:18:26 GMT
 published on: 2025-09-09 05:41:05  Newser Tue, 09 Sep 2025 10:41:05 GMT

Alzamend Neuro Inc
(NASDAQ:ALZN) 

ALZN stock logo

Alzamend Neuro is preclinical stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders. With our two current and future product candidates, we aim to bring treatments or cures to market at a reasonable cost as quic...

Founded: 2016
CEO: Stephan Jackman  
Sector:
Industry:

Share this website to your friends